MicroRNA-mRNA Pairs Associated with Outcome in AML: From in vitro Cell-based Studies to AML Patients

Cytarabine is the primary chemotherapeutic agent used for treatment of AML. Disease relapse after initial remission remains one of the most pressing therapeutic challenges in the treatment of AML. Relapsed disease is often resistant to cytarabine and subsequent salvage therapy is ineffective. Rec...

Full description

Bibliographic Details
Main Authors: Neha S Bhise, Lata eChauhan, Miyoung eShin, Xueyuan eCao, Stanley ePounds, Vishal eLamba, Jatinder K Lamba
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00324/full